Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 Vaccination Before Initiating Rituximab Treatment Induces Strong Serological Response in Autoimmune Rheumatic Disease, Reducing Post-Pandemic Concerns About the Impact of Rituximab.
Ammitzbøll C, Thomsen MK, Bartels LE, Hansen CB, Hermansen MF, Hänel M, Klose-Jensen R, Larsen ML, Lauritsen MO, Mistegaard CE, Mikkelsen S, Olesen JBM, Næser EU, Nielsen MA, Erikstrup C, Garred P, Hauge EM, Troldborg A. Ammitzbøll C, et al. Among authors: nielsen ma. ACR Open Rheumatol. 2024 Aug;6(8):519-528. doi: 10.1002/acr2.11681. Epub 2024 Jun 23. ACR Open Rheumatol. 2024. PMID: 38923834 Free PMC article.
Increased synovial galectin-3 induce inflammatory fibroblast activation and osteoclastogenesis in patients with rheumatoid arthritis.
Nielsen MA, Køster D, Greisen S, Troldborg A, Stengaard-Pedersen K, Junker P, Hørslev-Petersen K, Hetland ML, Østergaard M, Hvid M, Leffler H, Kragstrup TW, Deleuran B. Nielsen MA, et al. Scand J Rheumatol. 2023 Jan;52(1):33-41. doi: 10.1080/03009742.2021.1992860. Epub 2022 Jan 13. Scand J Rheumatol. 2023. PMID: 35023445
A disintegrin and metalloprotease-17 and galectin-9 are important regulators of local 4-1BB activity and disease outcome in rheumatoid arthritis.
Nielsen MA, Andersen T, Etzerodt A, Kragstrup TW, Rasmussen TK, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Junker P, Østergaard M, Hvid M, Moestrup SK, Deleuran B. Nielsen MA, et al. Rheumatology (Oxford). 2016 Oct;55(10):1871-9. doi: 10.1093/rheumatology/kew237. Epub 2016 Jun 21. Rheumatology (Oxford). 2016. PMID: 27330157 Clinical Trial.
The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression.
Kragstrup TW, Greisen SR, Nielsen MA, Rhodes C, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Junker P, Østergaard M, Hvid M, Vorup-Jensen T, Robinson WH, Sokolove J, Deleuran B. Kragstrup TW, et al. Among authors: nielsen ma. Arthritis Res Ther. 2016 Mar 11;18:61. doi: 10.1186/s13075-016-0964-7. Arthritis Res Ther. 2016. PMID: 26968800 Free PMC article. Clinical Trial.
Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naïve Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts.
Nielsen MA, Køster D, Mehta AY, Stengaard-Pedersen K, Busson P, Junker P, Hørslev-Petersen K, Hetland ML, Østergaard M, Hvid M, Leffler H, Kragstrup TW, Cummings RD, Deleuran B. Nielsen MA, et al. Cells. 2023 Jan 15;12(2):327. doi: 10.3390/cells12020327. Cells. 2023. PMID: 36672263 Free PMC article.
Gal-3 blocks the binding between PD-1 and pembrolizumab.
Greisen SR, Bendix M, Nielsen MA, Pedersen K, Jensen NH, Hvid M, Mikkelsen JH, Drace T, Boesen T, Steiniche T, Schmidt H, Deleuran B. Greisen SR, et al. Among authors: nielsen ma. J Immunother Cancer. 2024 Oct 2;12(10):e009952. doi: 10.1136/jitc-2024-009952. J Immunother Cancer. 2024. PMID: 39357979 Free PMC article.
138 results